What are the differences in myopathy between hydrophilic and lipophilic statins?
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
The evidence does not consistently show significant differences in the risk of statin-associated myopathy between hydrophilic and lipophilic statins, although hypotheses exist regarding potentially lower myopathy risk for hydrophilic statins due to reduced muscle cell diffusion.
Fields of Study & Subjects
Lipoproteins and Cardiovascular Health
Cancer
Lipids
and Metabolism
Muscle Physiology and Disorders
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 26 March 2026
- Language
- EN